lovastatin has been researched along with Peritoneal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arslan, E; Caglayan, K; Halaclar, B; Oz, B; Sipahi, M; Talih, T | 1 |
| Babenko, TI; Eliseeva, MY; Kalzhanov, ZhR; Kosmas, IP; Malvasi, A; Mazitova, MI; Medvediev, MV; Mynbaev, OA; Stark, M; Tinelli, A | 1 |
| Imai, A; Suzuki, N | 1 |
3 other study(ies) available for lovastatin and Peritoneal Diseases
| Article | Year |
|---|---|
Comparison of lovastatin and hyaluronic acid/carboxymethyl cellulose on experimental created peritoneal adhesion model in rats.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Hyaluronic Acid; Lovastatin; Peritoneal Diseases; Random Allocation; Rats; Rats, Wistar; Tissue Adhesions | 2014 |
A personalized adhesion prevention strategy: E. Arslan, T. Talih, B. Oz, B. Halaclar, K. Caglayan, M. Sipahi, Comparison of lovastatin and hyaluronic acid/carboxymethyl cellulose on experimental created peritoneal adhesion model in rats, Int. J. Surg. 12
Topics: Animals; Female; Hyaluronic Acid; Lovastatin; Peritoneal Diseases; Tissue Adhesions | 2014 |
HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.
Topics: Actin Cytoskeleton; Cell Line; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Peritoneal Diseases; Plasminogen Inactivators; rhoA GTP-Binding Protein; Signal Transduction; Tissue Adhesions | 2010 |